Related Articles
Construction of phosphorylatable chimeric monoclonal antibody CC49 with a tyrosine srC kinase recognition site.
Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chains.
Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas
Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype
PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW)